{"id":1530,"date":"2024-02-12T16:27:42","date_gmt":"2024-02-12T16:27:42","guid":{"rendered":"https:\/\/gebro.es\/business-development-e-innovacion\/licensing-out\/"},"modified":"2025-02-14T17:00:47","modified_gmt":"2025-02-14T17:00:47","slug":"licensing-out","status":"publish","type":"page","link":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/","title":{"rendered":"Licensing out"},"content":{"rendered":"
\n
<\/i><\/a><\/span><\/span><\/div>\n<\/section>\n\n
\n
\n
\n
\n

\n Licensing-Out<\/h1>\n <\/div>\n
\n
\n

El Grup Gebro Holding comercialitza les seves pr\u00f2pies marques i tamb\u00e9 estableix acords amb tercers per a la seva comercialitzaci\u00f3.<\/p>\n\n <\/div>\n \n <\/div>\n <\/div>\n<\/section>\n\n\n

\n\n
\n

Productes RX<\/h2>\n <\/div>\n\n
\n \n
\n \"\"\n <\/div>\n
\n

\n Seractil\u00ae\n <\/h3>\n

Principio activo<\/b>: dexibuprofeno 200 mg, 300 mg, 400 mg
\nIndicaci\u00f3n<\/b>: antiinflamatorio, analg\u00e9sico, antipir\u00e9tico
\nForma<\/strong>: fcomprimidos recubiertos con pel\u00edcula, sobres<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Nocutil\u00ae\n <\/h3>\n

Principio activo<\/strong>: desmopresina
\nIndicaci\u00f3n<\/strong>: enuresis nocturna (comprimidos), diabetes ins\u00edpida
\nForma<\/strong>: spray nasal (0.1 mg\/ml), comprimidos (0.1 mg, 0.2 mg)<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Pridax\u00ae\n <\/h3>\n

Principio activo<\/strong>: alprostadil 20 \u00b5g\/ml concentrado para perfusi\u00f3n
\nIndicaci\u00f3n<\/strong>: ttratamiento de la enfermedad oclusiva arterial perif\u00e9rica (estadios III-IV de Fontaine)
\nForma<\/strong>: ampollas que contienen etanol<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Xylanaest\u00ae purum\n <\/h3>\n

Principio activo<\/strong>: lidoca\u00edna-HCl (0.5%, 1%, 2%)
\nIndicaci\u00f3n<\/strong>: anest\u00e9sico local (en AT, CH: espec\u00edfico para terapia neural tambi\u00e9n como xiloneural\u00ae)
\nForm<\/strong>: ampollas, viales<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Mepinaest\u00ae\n <\/h3>\n

Principio activo<\/strong>: mepivaca\u00edna-HCl (0,5%, 1%, 2%)
\nIndicaci\u00f3n<\/strong>: local anaesthetic
\nForma<\/strong>: ampollas, viales<\/p>\n<\/div>\n <\/div>\n<\/div>\n <\/section>\n\n\n

\n\n
\n

Productes OTC<\/h2>\n <\/div>\n\n
\n \n
\n \"\"\n <\/div>\n
\n

\n Normhydral\u00ae (para adolescentes y adultos)\n <\/h3>\n

Principio activo<\/strong>: Mezcla de rehidrataci\u00f3n oral
\nIndicaci\u00f3n<\/strong>: Reemplazo de las p\u00e9rdidas de l\u00edquidos y electrolitos resultantes de diarrea y v\u00f3mitos
\nForma<\/strong>: sobres, 13,1 mg<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Normolyt\u00ae (for infants and children)\n <\/h3>\n

Principio activo<\/strong>: Mezcla de rehidrataci\u00f3n oral
\nIndicaci\u00f3n<\/strong>: Reemplazo de las p\u00e9rdidas de l\u00edquidos y electrolitos resultantes de diarrea y v\u00f3mitos
\nForm<\/strong>: sobres, 5,4 mg<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Laxasan\u00ae\n <\/h3>\n

Principio activo<\/strong>: psicosulfato de natrio
\nIndicaci\u00f3n<\/strong>: estre\u00f1imiento
\nForma<\/strong>: gotas<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Eu-Med\u00ae\n <\/h3>\n

Principio activo<\/strong>: Dexibuprofeno 200 mg
\nIndicaci\u00f3n<\/strong>: tratamiento del dolor y la fiebre en resfriados e infecciones similares a la gripe
\nForma<\/strong>: comprimidos recubiertos con pel\u00edcula<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Makutussin\u00ae (registro suizo)\n <\/h3>\n

Principio activo<\/strong>: fosfato de code\u00edna hemihidrato
\nIndication<\/strong>: Alivio de la tos, especialmente tos seca
\nForma<\/strong>: gotas<\/p>\n<\/div>\n <\/div>\n<\/div>\n <\/section>\n\n\n

\n\n
\n

Productes OTC (herbolog\u00eda)<\/h2>\n <\/div>\n\n
\n \n
\n \"\"\n <\/div>\n
\n

\n Gotas de tomillo\n <\/h3>\n

Principio activo<\/strong>: Extracto de tomillo 972 mg\/g
\nForm<\/strong>: gotas orales (Herbolog\u00eda tradicional, Contiene alcohol)<\/p>\n<\/div>\n <\/div>\n<\/div>\n <\/section>\n\n\n

\n
\n

Alpinamed AG<\/h2>\n

Competencia en la extracci\u00f3n de plantas medicinales<\/p>\n

\n

Alpinamed AG pertenece al grupo austr\u00edaco Gebro Holding GmbH. La compa\u00f1\u00eda es en la actualidad uno de los principales fabricantes de extractos est\u00e1ndar y especiales. Estos se utilizan en muchos productos farmac\u00e9uticos, en suplementos nutricionales y en productos cosm\u00e9ticos innovadores.<\/p>\n

Como proveedor integral, ofrecemos soluciones completas:<\/p>\n

    \n
  • Extractos en forma l\u00edquida o seca.<\/li>\n
  • Productos derivados en suministros a granel.<\/li>\n
  • \u00a0Productos terminados para la venta<\/li>\n<\/ul>\n\n <\/div>\n <\/div>\n
    \n \"\"\n <\/div>\n<\/section>\n\n\n
    \n\n
    \n

    Suplementos nutricionales (ingredients naturales)<\/p>\n

    Sin gluten y sin lactosa\r\n<\/p>\n <\/div>\n\n

    \n \n
    \n \"\"\n <\/div>\n
    \n

    \n L\u00ednea de productos Alpinamed\u00ae Lingonberry\n <\/h3>\n

    Ingredientes<\/strong>: extracto de ar\u00e1ndanos rojos frescos
    \nUso<\/strong>: suplementos nutricionale
    \nForma<\/strong>: c\u00e1psulas, sobres, concentrado para soluci\u00f3n oral, caramelos masticables<\/p>\n<\/div>\n <\/div>\n<\/div>\n

    \n \n
    \n \"\"\n <\/div>\n
    \n

    \n L\u00ednea de productos Alpinamed\u00ae Curcuma\n <\/h3>\n

    Ingredientes<\/strong>: extracto de ra\u00edz de curcuma y curcumina
    \nUso<\/strong>: Suplemento alimenticio para el apoyo de la salud intestinal y musculoesquel\u00e9tica.
    \nForma<\/strong>: c\u00e1psulas, gotas orales<\/p>\n<\/div>\n <\/div>\n<\/div>\n

    \n \n
    \n \"\"\n <\/div>\n
    \n

    \n Alpinamed\u00ae Black Garlic \u2013 todos los beneficios sin el olor\n <\/h3>\n

    Ingredientes<\/strong>: ajo negro (ajo fermentado), Vitamina B1 + B2,
    \nUso<\/strong>: Apoyo diet\u00e9tico para la salud cardiovascular y del sistema nervioso
    \nForma<\/strong>: c\u00e1psulas blandas<\/p>\n<\/div>\n <\/div>\n<\/div>\n <\/section>\n\n\n

    \n
    \n

    Contact manufacture<\/h2>\n

    La flexibilidad y el servicio orientado al cliente son nuestra fortaleza<\/p>\n

    \n \n <\/div>\n <\/div>\n
    \n \"\"\n <\/div>\n<\/section>\n\n\n
    \n
    \n

    Producci\u00f3n<\/h3>\n

    Gebro Pharma produce productos medicinales, suplementos alimenticios\/productos diet\u00e9ticos y cosm\u00e9ticos en diversas formas farmac\u00e9uticas. Suministramos a socios en m\u00e1s de 20 pa\u00edses en todo el mundo, cumpliendo con las Pr\u00e1cticas de Fabricaci\u00f3n de Calidad Actuales (cGMP).<\/p>\n<\/p>\n <\/div>\n

    \n
    \n \"\"\n <\/div>\n
    \n

    \n Solid Forms\n <\/p>\n

    (Maximum batch of 400 kg)<\/p>\n

      \n
    • Tablets<\/li>\n
    • Film coated tablets<\/li>\n
    • Blister packaging of various forms<\/li>\n
    • Power in tins<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n
      \n
      \n \"\"\n <\/div>\n
      \n

      \n Injection solutions\n <\/p>\n

      Injection solutions Terminal sterile products with a maximum batch size of 500 litres:<\/p>\n

        \n
      • aqueous solutions<\/li>\n
      • glass ampoules<\/li>\n
      • vials<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n
        \n
        \n \"\"\n <\/div>\n
        \n

        \n Liquid Forms\n <\/p>\n

        Power in tins (maximum batch size of 2.000 litres):<\/p>\n

          \n
        • aqueous solution<\/li>\n
        • alcohol solution<\/li>\n
        • glass or plastic bottles in combination with various types of seal, such as drip plug, nasal spray<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n <\/section>\n\n\n
          \n
          \n

          Servicios<\/h3>\n <\/div>\n
          \n
          \n \"\"\n <\/div>\n
          \n

          \n An\u00e1lisis\n <\/p>\n

          Control de entrada de mercanc\u00edas de materias primas.<\/p>\n

            \n
          • Liberaci\u00f3n de lotes conforme a GMP<\/li>\n
          • Pruebas de estabilidad<\/li>\n
          • Desarrollo de m\u00e9todos anal\u00edticos.<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n
            \n
            \n \"\"\n <\/div>\n
            \n

            \n Distribuci\u00f3n\n <\/p>\n

            En asociaci\u00f3n con nuestra actividad mayorista, tambi\u00e9n nos complace ofrecerle para el mercado austriaco:<\/p>\n

              \n
            • Almacenamiento y distribuci\u00f3n de productos farmac\u00e9uticos,<\/li>\n
            • Tambi\u00e9n como productos refrigerados dependiendo de la cantidad.<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n
              \n
              \n \"\"\n <\/div>\n
              \n

              \n Apoyo regulatorio\n <\/p>\n

                \n
              • Soporte de gesti\u00f3n del ciclo de vida (informe de cambios)<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n <\/section>\n\n\n
                \n
                \n

                Innovaci\u00f3n y desarrollo<\/h2>\n

                Repensar, reinventar, optimizar los medicamentos<\/p>\n

                \n

                Estamos poniendo a los pacientes y profesionales de la salud en el centro de su impulso. Nos apasiona crear nuestros propios proyectos de innovaci\u00f3n colaborando con reconocidos grupos de investigaci\u00f3n p\u00fablicos y privados, as\u00ed como con instituciones nacionales de alto nivel.<\/p>\n

                En nuestra sede en Austria, ofrecemos servicios completos de desarrollo, desde la idea hasta el producto terminado.
                \nUn laboratorio gal\u00e9nico equipado con tecnolog\u00eda de \u00faltima generaci\u00f3n.<\/p>\n

                  \n
                • Desarrollo, escalado y resoluci\u00f3n de problemas de formas farmac\u00e9uticas s\u00f3lidas, l\u00edquidas y semis\u00f3lidas.<\/li>\n
                • Desarrollo de recetas incluyendo la producci\u00f3n de muestras de preestabilidad.<\/li>\n
                • Escalado y apoyo en la transferencia del producto a nuestras instalaciones de producci\u00f3n hasta la validaci\u00f3n del proceso.<\/li>\n
                • Desarrollo y validaci\u00f3n de todos los m\u00e9todos anal\u00edticos comunes.<\/li>\n
                • An\u00e1lisis qu\u00edmico-f\u00edsico de series de pruebas, muestras de preestabilidad y estabilidad seg\u00fan las directrices de la ICH.<\/li>\n<\/ul>\n\n <\/div>\n <\/div>\n
                  \n \"\"\n <\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":1528,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-business.blade.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1530","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nLicensing out - Gebro Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Licensing out - Gebro Pharma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/\" \/>\n<meta property=\"og:site_name\" content=\"Gebro Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-14T17:00:47+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/licensing-out\\\/\",\"url\":\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/licensing-out\\\/\",\"name\":\"Licensing out - Gebro Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/#website\"},\"datePublished\":\"2024-02-12T16:27:42+00:00\",\"dateModified\":\"2025-02-14T17:00:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/licensing-out\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/licensing-out\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/licensing-out\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/gebro.es\\\/ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business Development & innovaci\u00f3\",\"item\":\"https:\\\/\\\/gebro.es\\\/ca\\\/business-development-i-innovacio\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Licensing out\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/gebro.es\\\/ca\\\/#website\",\"url\":\"https:\\\/\\\/gebro.es\\\/ca\\\/\",\"name\":\"Gebro Pharma\",\"description\":\"At Gebro Pharma we improve your health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/gebro.es\\\/ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Licensing out - Gebro Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/","og_locale":"ca_ES","og_type":"article","og_title":"Licensing out - Gebro Pharma","og_url":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/","og_site_name":"Gebro Pharma","article_modified_time":"2025-02-14T17:00:47+00:00","twitter_card":"summary_large_image","twitter_misc":{"Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/","url":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/","name":"Licensing out - Gebro Pharma","isPartOf":{"@id":"https:\/\/gebro.es\/ca\/#website"},"datePublished":"2024-02-12T16:27:42+00:00","dateModified":"2025-02-14T17:00:47+00:00","breadcrumb":{"@id":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/licensing-out\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/gebro.es\/ca\/"},{"@type":"ListItem","position":2,"name":"Business Development & innovaci\u00f3","item":"https:\/\/gebro.es\/ca\/business-development-i-innovacio\/"},{"@type":"ListItem","position":3,"name":"Licensing out"}]},{"@type":"WebSite","@id":"https:\/\/gebro.es\/ca\/#website","url":"https:\/\/gebro.es\/ca\/","name":"Gebro Pharma","description":"At Gebro Pharma we improve your health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gebro.es\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"}]}},"_links":{"self":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/pages\/1530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/comments?post=1530"}],"version-history":[{"count":1,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/pages\/1530\/revisions"}],"predecessor-version":[{"id":1533,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/pages\/1530\/revisions\/1533"}],"up":[{"embeddable":true,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/pages\/1528"}],"wp:attachment":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/media?parent=1530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}